Quick Answer
Twist Bioscience Corp reported Stockholders Equity of $472.96 million for fiscal year 2025.
Twist Bioscience Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $472.96M | +0.1% |
| 2024 | $472.69M | -24.2% |
| 2023 | $623.43M | -21.0% |
| 2022 | $789.38M | +35.9% |
| 2021 | $580.82M | +72.7% |
| 2020 | $336.26M | +121.1% |
| 2019 | $152.08M | +175.5% |
| 2018 | -$201.42M | -51.0% |
| 2017 | -$133.36M | -74.1% |
| 2016 | -$76.61M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $456.10M | +0.0% | -3.6% |
| September 30, 2025 | $472.96M | +0.1% | -1.1% |
| June 30, 2025 | $478.20M | -2.6% | +8.7% |
| March 31, 2025 | $440.11M | -21.4% | -3.5% |
| December 31, 2024 | $455.94M | -22.7% | -3.5% |
| September 30, 2024 | $472.69M | -24.2% | -3.8% |
| June 30, 2024 | $491.14M | -25.3% | -12.3% |
| March 31, 2024 | $560.13M | -20.4% | -5.1% |
- Twist Bioscience Corp showed an increase of +0.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Twist Bioscience Corp’s stockholders equity has grown by 717.3% (from -$76.61 million to $472.96 million).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: